Global micro-invasive glaucoma surgery devices market is projected to display a robust growth represented by a CAGR of 47.10% during 2017 – 2022, chiefly driven by several MIGS devices entering the market in next five years

Date: 25 May 2017

Over the recent years, the global micro-invasive glaucoma surgery device industry has been growing rapidly as the global sales of iStent device by Glaukos which was the only commercially available device in United States has witnessed rapid growth post its FDA approval in 2012. Globally, the growth in micro-invasive glaucoma surgery device market is driven by several MIGS devices entering the market in next five years, rising number of glaucoma patients and rapidly aging population.

According to Azoth Analytics research report, “GlobalMicro-Invasive Glaucoma Surgery (MIGS) Devices Market (By Target, By Surgery,By End User, By Region, By Country): Opportunities and Forecast (2017-2022) - By Target (Trabecular Meshwork, Suprachoroidal Space), By Surgery (Glaucoma – Cataract, Standalone), By End User (HOPD, ASCs), By Region (N. America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, Japan, South Korea, Australia, Brazil, South Africa)”, global market is projected to display a robust growth represented by a CAGR of 47.10% during 2017 – 2022, chiefly driven by several MIGS devices entering the market in next five years, rising number of glaucoma patients and rapidly aging population, high safety profile and reduced dependency on prescription eye drops.

Glaucoma is a painless and asymptomatic eye disease which on progression causes irreversible damage loss. According to WHO (World Health Organisation), glaucoma is the second biggest cause of blindness in the world. Glaucoma incidences will continue to increase with aging population around the world. Thus, Glaucoma treatment market holds huge potential. Micro-invasive glaucoma surgery (MIGS) devices market is the new treatment options for glaucoma patients. These devices are currently recommended for treating moderate form of glaucoma and are approved for implantation in combination with cataract surgery or as a separate procedure. MIGS devices are considered the bridging gap between prescription eye drops and highly invasive glaucoma surgical procedures like trabeculectomy and tube shunts.

iStent was the first MIGS device to gain FDA approval. Strong growth of iStent in the US market has shown the immense potential that these devices hold. Market is currently concentrated in United States with iStent being the only commercially available device. FDA approval of CyPass microstent and Xen Gel Stent in 2016 and expected approval of other MIGS devices in next five years and their comercialization will drive the market during forecasted period. There is high demand for MIGS devices in glaucoma treatment as they provide mild lowering of intraocular pressure, have high safety profile and are minimally invasive.

The report titled “GlobalMicro-Invasive Glaucoma Surgery (MIGS) Devices Market (By Target, By Surgery,By End User, By Region, By Country): Opportunities and Forecast (2017-2022) - By Target (Trabecular Meshwork, Suprachoroidal Space), By Surgery (Glaucoma – Cataract, Standalone), By End User (HOPD, ASCs), By Region (N. America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, Japan, South Korea, Australia, Brazil, South Africa)” has covered and analysed the potential of Global Micro-Invasive Glaucoma Surgery Device Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also highlights market entry strategies for various companies across the globe.

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Micro-Invasive Glaucoma Surgery Device Market on the basis of By Target (Trabecular Meshwork, Suprachoroidal Space), By Surgery (Glaucoma in conjunction with Cataract and Stand Alone Glaucoma, By End User (Hospital Outpatient Departments (HOPDs) and Ambulatory Surgery Centers (ASCs)), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., Germany, France, Japan, South Korea, Australia, Brazil and South Africa).

...